Better health.
Within reach.
Every day.

Hikma launches generic version of Vyvanse® following FDA approval

Hikma launches Vancomycin Hydrochloride for Injection, USP, in the US

Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa

Watch a video message from our new CEO, Riad Mishlawi

#OwnYourCareer@Hikma

Meet Filipa Calisto, Associate Director, Portfolio & Commercial Operations, EU, and discover why she likes working at Hikma!

Meet Kimberly Lembo, Associate Director, Contract Lifecycle Management and Systems, US and discover why she loves working at Hikma!

#OwnYourCareer@Hikma

Meet Alexander Liang, Trade Operations, US and discover why he loves working at Hikma!

Read the latest blog post by Lana Ghanem, Managing Director, Hikma Ventures and Vice President, Digital Health Investments & Partnerships - Investing in the disruptive future of the pharmaceutical industry.

Join us in helping to put better health within reach for millions of people

Our 2022 Sustainability Report

Our 2022 Annual Report